Advances in recombinant antibody manufacturing
Достижения в производстве рекомбинантных антител
2016-03-02
SCID: 54.1/4z62jvps
Discuss with AI
Chinese hamster ovary cellshost cell line engineeringmonoclonal antibody expressionpost-translational modificationsrecombinant antibody manufacturing
Figures from the paper
Abstract (AI)
Since the first use of Chinese hamster ovary (CHO) cells for recombinant protein expression, production processes have steadily improved through numerous advances. In this review, we have highlighted several key milestones that have contributed to the success of CHO cells from the beginning of their use for monoclonal antibody (mAb) expression until today. The main factors influencing the yield of a production process are the time to accumulate a desired amount of biomass, the process duration, and the specific productivity. By comparing maximum cell densities and specific growth rates of various expression systems, we have emphasized the limiting parameters of different cellular systems and comprehensively described scientific approaches and techniques to improve host cell lines. Besides the quantitative evaluation of current systems, the quality-determining properties of a host cell line, namely post-translational modifications, were analyzed and compared to naturally occurring polyclonal immunoglobulin fractions from human plasma. In summary, numerous different expression systems for mAbs are available and also under scientific investigation. However, CHO cells are the most frequently investigated cell lines and remain the workhorse for mAb production until today.
Key Findings
1
CHO cells have remained the dominant workhorse for recombinant monoclonal antibody production since their initial adoption.
2
Comparisons of maximum cell densities and specific growth rates identify key limitations across different antibody-expression systems.
3
Host-cell post-translational modifications are critical quality attributes and were compared with naturally occurring human plasma polyclonal immunoglobulins.
4
Multiple recombinant antibody expression systems are available and under investigation, but CHO cells remain the most extensively studied.
5
Production yield is primarily determined by biomass accumulation time, process duration, and cell-specific productivity.
6
Scientific strategies and technologies have been developed to improve host cell lines and enhance recombinant antibody manufacturing.
Research Object
Chinese hamster ovary (CHO) cell-based recombinant monoclonal antibody production systems
Research Subject
Production yield, process performance, host-cell-line limitations and post-translational product-quality properties of recombinant antibody expression systems
Publication Details
Publication Date
2016-03-02
Journal
Publisher
ISSN
Cited by
418
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai2
Cited by6
HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors2021
Bioprocess Design Considerations for Cultured Meat Production With a Focus on the Expansion Bioreactor2019
Recent advances in CHO cell line development for recombinant protein production2020
Oxidative stress‐alleviating strategies to improve recombinant protein production in CHO cells2019
Strategies and Considerations for Improving Recombinant Antibody Production and Quality in Chinese Hamster Ovary Cells2022
Understanding the effect of temperature downshift on CHO cell growth, antibody titer and product quality by intracellular metabolite profiling and in vivo monitoring of redox state2023